Centre for Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London.
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16. doi: 10.1097/QAI.0b013e318269c414.
The mechanism of CD4 T-cell decline in HIV-1 infection is unclear, but the association with plasma viral RNA load suggests viral replication is involved. Indeed, viremic controller patients with low viral RNA loads typically maintain high CD4 T-cell counts. Within a local cohort of 86 viremic controllers, we identify a subgroup (18 "discord controllers") with low CD4 T-cell counts that present clinical uncertainty. The underlying mechanism accounting for CD4 T-cell decline in the face of low or undetectable plasma (RNA) viral load remains unresolved. The objective of this study was to investigate the viral and host immune system dynamics in discord controllers by measuring cellular HIV-1 DNA load, T-cell populations, and T-cell activation markers.
We compared discord controllers (viral RNA load <2000 copies/mL, <450 CD4 T-cells/mm) with typical controllers (viral RNA load <2000 copies/mL, >450 CD4 T-cells/mm) and progressors (viral RNA load >10,000 copies/mL, <450 CD4 T-cells/mm). We quantified CD4/CD8 naive/central memory/effector memory subsets (CD45RA/RO ± CD62L), activation levels (CD38HLA-DR), and HIV-1 DNA load.
Discord controllers resembled progressors showing high viral DNA load, depletion of naive CD4 T-cells, and higher activation in all CD4 T-cell subsets, compared with typical controllers. They were similar to typical controllers with lower CD8 T-cell activation compared with progressors.
Our data are consistent with a relationship between CD4 T-cell activation and disease progression. HIV-1 DNA load may be a better marker of viral replication and disease progression than viral RNA load. Lower level CD8 T-cell activation correlates with low viral RNA load but not with disease progression or viral DNA load.
在 HIV-1 感染中,CD4 T 细胞下降的机制尚不清楚,但与血浆病毒 RNA 载量的关联表明病毒复制可能涉及其中。事实上,病毒血症控制者的病毒载量较低,通常会维持较高的 CD4 T 细胞计数。在当地的 86 名病毒血症控制者队列中,我们发现了一个亚组(18 名“不一致控制者”)的 CD4 T 细胞计数较低,存在临床不确定性。在面对低或无法检测到的血浆(RNA)病毒载量的情况下,导致 CD4 T 细胞下降的潜在机制仍未解决。本研究的目的是通过测量细胞 HIV-1 DNA 载量、T 细胞群和 T 细胞激活标志物,来研究不一致控制者中的病毒和宿主免疫系统动态。
我们比较了不一致控制者(病毒 RNA 载量 <2000 拷贝/mL,<450 CD4 T 细胞/mm)与典型控制者(病毒 RNA 载量 <2000 拷贝/mL,>450 CD4 T 细胞/mm)和进展者(病毒 RNA 载量>10,000 拷贝/mL,<450 CD4 T 细胞/mm)。我们量化了 CD4/CD8 幼稚/中央记忆/效应记忆亚群(CD45RA/RO±CD62L)、激活水平(CD38HLA-DR)和 HIV-1 DNA 载量。
与典型控制者相比,不一致控制者与进展者相似,表现出高病毒 DNA 载量、幼稚 CD4 T 细胞耗竭以及所有 CD4 T 细胞亚群的高激活。与进展者相比,他们与典型控制者的 CD8 T 细胞激活水平较低。
我们的数据与 CD4 T 细胞激活与疾病进展之间的关系一致。HIV-1 DNA 载量可能是比病毒 RNA 载量更好的病毒复制和疾病进展标志物。较低水平的 CD8 T 细胞激活与低病毒 RNA 载量相关,但与疾病进展或病毒 DNA 载量无关。